These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

766 related items for PubMed ID: 18670244

  • 1. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A, Ritsner MS.
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [Abstract] [Full Text] [Related]

  • 2. The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.
    Ritsner MS, Yorkov V, Ratner Y, Soifer P, Gibel A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1470-7. PubMed ID: 17669573
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Ratner Y, Gibel A, Yorkov V, Ritsner MS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1401-9. PubMed ID: 17669574
    [Abstract] [Full Text] [Related]

  • 4. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May 01; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

  • 5. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
    Kim SW, Shin IS, Kim JM, Lee SH, Lee YH, Yang SJ, Yoon JS.
    Hum Psychopharmacol; 2009 Oct 01; 24(7):565-73. PubMed ID: 19790174
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
    Zhao T, Park TW, Yang JC, Huang GB, Kim MG, Lee KH, Chung YC.
    Int Clin Psychopharmacol; 2012 Jul 01; 27(4):184-90. PubMed ID: 22426471
    [Abstract] [Full Text] [Related]

  • 11. Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone.
    Montes JM, Rodriguez JL, Balbo E, Sopelana P, Martin E, Soto JA, Delgado JF, Diez T, Villardaga I.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):383-8. PubMed ID: 17129654
    [Abstract] [Full Text] [Related]

  • 12. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J.
    Biol Psychiatry; 2004 Oct 15; 56(8):560-9. PubMed ID: 15476685
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.
    Fagerlund B, Søholm B, Fink-Jensen A, Lublin H, Glenthøj BY.
    Clin Neuropharmacol; 2007 Oct 15; 30(1):3-12. PubMed ID: 17272964
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
    Chouinard S, Stip E, Poulin J, Melun JP, Godbout R, Guillem F, Cohen H.
    Curr Med Res Opin; 2007 Mar 15; 23(3):575-83. PubMed ID: 17355738
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.